Latest market price
36.41
-0.24-0.65%
OverviewShort InterestFilings
OMCLQT47Omnicell, Inc.·NASDAQ
36.41-0.65%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
CERT-2.81%$10.71TDOC+1.41%$8.63GDRX+1.72%$3.55OMDA-4.70%$17.85HSTM+2.61%$34.58PRVA-0.93%$21.28PHR+0.00%$12.44SOPH-6.82%$7.11
Snapshot
Index—P/E37.93EPS (ttm)0.96Insider Own3.97%Shs Outstand45.48MPerf Week-1.51%
Market Cap1.66BForward P/E17.69EPS next Y2.06Insider Trans-1.17%Shs Float44.06MPerf Month8.36%
Enterprise Value1.53BPEG—EPS next Q0.40Short Float7.41%Perf Quarter-1.99%
Income44.00MP/S1.33EPS this Y42.02%Short Ratio4.93Perf Half Y-16.18%
Sales1.24BP/B1.26EPS next Y-15.54%ROA2.17%Short Interest3.27MPerf YTD-19.62%
Book/sh28.96P/C5.26EPS next 5Y-2.91%ROE3.50%52W High55.00 -33.80%Perf Year8.43%
Cash/sh6.93P/FCF11.42EPS past 3/5Y-28.26% -43.06%ROIC2.75%52W Low31.75 14.68%Perf 3Y2.36%
Dividend Est.—EV/EBITDA10.27Sales past 3/5Y-2.94% 5.85%Gross Margin45.14%Volatility5.26% 3.81%Perf 5Y-78.39%
Dividend TTM—EV/Sales1.23EPS Y/Y TTM124.40%Oper. Margin5.28%ATR (14)1.41Perf 10Y2.56%
Dividend Ex-Date—Quick Ratio1.45Sales Y/Y TTM5.51%Profit Margin3.59%RSI (14)53.77Recom2.50
Dividend Gr. 3/5Y—Current Ratio1.66EPS Q/Q13.73%SMA200.51%Beta0.88Target Price57.50
Payout0.00%Debt/Eq0.14Sales Q/Q-0.96%SMA505.17%Rel Volume1.84Prev Close36.65
Employees3,580LT Debt/Eq0.14EarningsFeb 04SMA200-6.55%Avg Volume587.16KPrice36.41
IPO DateAug 07, 2001Option/ShortYes / YesEPS/Sales Surpr.38.92% 1.12%Net Debt/EBITDA-0.84Volume1,078,689Change-0.65%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-31-26ReiteratedWells FargoOverweight$52 → $50
Jul-31-26ReiteratedKeybancOverweight$70 → $65
Apr-29-26ReiteratedCraig-HallumBuy$53 → $55
Mar-13-26ReiteratedUBS$53 → $60
Feb-06-26ReiteratedPiper SandlerOverweight$55 → $49
Jan-16-26ReiteratedUBS$53
Jan-08-26UpgradeKeybancSector Weight → Overweight$60
Jan-05-26ReiteratedWells FargoOverweight$35 → $52
Aug-11-25ReiteratedPiper SandlerOverweight$61 → $55
May-14-25UpgradeWells FargoEqual Weight → Overweight$40 → $35
Latest News· Times ET
Oct-29-26
Oct-29-2607:18PM
Omnicell, Inc. (OMCL) Q3 2026 Earnings Call Transcriptseekingalpha.com
05:15PM
Omnicell Q3 Earnings Call Highlightsmarketbeat.com
10:31AM
Here's What Key Metrics Tell Us About Omnicell (OMCL) Q3 Earningszacks.com
09:20AM
Omnicell (NASDAQ:OMCL) Profit Beat and Raised Guidance Offset Soft Q4 Revenue OutlookChartMill
08:46AM
Omnicell (OMCL) Q3 Earnings and Revenues Top Estimateszacks.com
06:30AM
Omnicell Announces Third Quarter 2026 Financial Resultsbusinesswire.com
Oct-22-26
Oct-22-2605:25PM
3 Small-Cap Stocks We Approach with CautionYahoo
Oct-13-26
Oct-13-2610:25AM
Is This the Right Time to Retain Omnicell Stock in Your Portfolio?zacks.com
Oct-11-26
Oct-11-2602:58AM
Financial Contrast: Baxter International (NYSE:BAX) and Omnicell (NASDAQ:OMCL)defenseworld.net
Oct-08-26
Oct-08-2604:01PM
Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026businesswire.com
Oct-06-26
Oct-06-2608:08AM
1 Healthcare Stock with Exciting Potential and 2 We Find RiskyYahoo
Oct-02-26
Oct-02-2610:41AM
Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?zacks.com
Sep-25-26
Sep-25-2608:06AM
Robotics Earnings Week: Momentum vs. Value as Four Automation Names ReportChartMill
Sep-18-26
Sep-18-2606:47AM
Strength Seen in Tempus (TEM): Can Its 14.9% Jump Turn into More Strength?Yahoo
Sep-16-26
Sep-16-2610:41AM
Here's Why Omnicell (OMCL) is a Strong Value Stockzacks.com
Company

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,2441,1851,1121,147—————
Cost of Goods Sold Incl. D&A683677641647—————
Gross Profit561508471500—————
Selling, General and Administrative Excl. Other409409380426—————
Research and Development87889093—————
Other Operating Expense0-110—————
Operating Income65120-19—————
Interest Expense4450—————
Unusual Expense
—————————
Non-Operating Income (Expense)5430-1—————
Net Income Before Taxes681126-20—————
Income Taxes249130—————
Consolidated Net Income44213-20—————
Net Income From Continuing Operations44213-20—————
Net Income44213-20—————
EPS (Recurring)0.970.040.27-0.45—————
EPS (Basic, Before Extraordinaries)0.970.040.27-0.45—————
EPS (Diluted)0.960.040.27-0.45—————
EBITDA14910212080—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio37.931,022.57164.89——————
Price To Sales Ratio1.351.761.841.48—————
Gross Margin45.1042.8742.3643.59—————
Operating Margin5.231.010.00-1.66—————
Net Margin3.540.171.17-1.74—————
Shares Outstanding46464645—————
Market Capitalization1,6752,0842,0481,693—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$54.68$47.55$40.42$33.30$26.17● Close Price0.00M0.32M0.64M0.95M1.27MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Njoku NnamdiPresident & COOAug 17 '26Sale36.853,083113,609161,224Aug 18
LIPPS RANDALL ACHAIRMAN, CEOJul 15 '26Sale47.0010,000470,000345,861Jul 17
Njoku NnamdiEVP, Chief Operating OfficerMay 18 '26Sale43.223,090133,550154,785May 19
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERMay 18 '26Sale43.225,025217,181112,783May 19
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERMar 16 '26Sale34.697,405256,87996,717Mar 17
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERFeb 17 '26Sale36.594,243155,25185,496Feb 18
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERJan 08 '26Sale49.906,106304,68991,674Jan 12
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERDec 16 '25Sale43.3027812,03797,780Dec 17
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERDec 03 '25Sale39.906,106243,62998,282Dec 05
LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEODec 01 '25Option Exercise27.7028,250782,525414,898Dec 03
LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEODec 01 '25Sale35.9728,2501,016,093386,648Dec 03
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERNov 17 '25Sale34.903,473121,208104,388Nov 18
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERSep 12 '25Sale33.253,880129,010110,653Sep 16
LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEOMar 14 '25Buy33.1310,561349,874333,610Mar 18
PARRISH MARK WDirectorDec 10 '24Sale47.3012,000567,63858,427Dec 12
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.